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BRIEF DEFINITIVE REPORT
        Regulatory T (T reg) cells are known to play 
an important role in the control of destructive 
infl  ammatory responses (  1  ). Most frequently 
studied is the naturally occurring population of 
CD4     CD25     Foxp3      T reg cells that develops 
in the thymus. These cells are important in the 
control of a wide range of immune-mediated 
pathologies, including autoimmunity, colitis, 
and chronic infection. Nevertheless, T cells with 
regulatory function can also be generated in the 
periphery from the naive T cell pool after, for 
example, the oral administration of antigen or 
the targeting of peptide ligands to DCs in vivo 
(  2  –  4  ). Foxp3      T cells can also be generated in 
the presence of TGF-      (  5  –  10  ). 
  Although peripheral T cells can begin to 
express Foxp3 and acquire regulatory function, 
the relevance of this pathway under normal 
physiological conditions remains unclear. This is 
compounded by the fact that induced Foxp3      
T cells look phenotypically similar to the naturally 
occurring population. Consequently, it is diffi   -
cult to determine what proportion of peripheral 
CD25     Foxp3      T reg cells had their regulatory 
function imprinted in the periphery. 
  The ability to induce T reg cell populations 
from the naive pool may be of particular benefi  t 
in the intestine. The extensive immune system 
here must cope with the challenge of mount-
ing protective immunity to occasional patho-
gens while remaining tolerant to dietary antigen 
and the commensal fl  ora. It may therefore be 
crucial to generate T reg cells specifi  c for these 
types of antigen, in addition to those T reg cells 
selected for their high affi   nity to self-antigen in 
the thymus. 
  DCs are thought to play an important role in 
the generation of T reg cell responses. DCs pre-
sent in the gut-associated lymphoid tissue (GALT) 
possess several functional specializations that sug-
gest they may be capable of inducing regulatory-
type responses (  11, 12  ). However, a clear role 
for these cells in the extrathymic development of 
Foxp3      T reg cells remains to be demonstrated. 
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  Foxp3     regulatory T (T reg) cells play a key role in controlling immune pathological re-
actions. Many develop their regulatory activity in the thymus, but there is also evidence for 
development of Foxp3      T reg cells from naive precursors in the periphery. Recent studies 
have shown that transforming growth factor (TGF)-      can promote T reg cell development 
in culture, but little is known about the cellular and molecular mechanisms that mediate 
this pathway under more physiological conditions. Here, we show that after antigen activa-
tion in the intestine, naive T cells acquire expression of Foxp3. Moreover, we identify a 
population of CD103      mesenteric lymph node dendritic cells (DCs) that induce the devel-
opment of Foxp3      T reg cells. Importantly, promotion of T reg cell responses by CD103      
DCs is dependent on TGF-      and the dietary metabolite, retinoic acid (RA). These results 
newly identify RA as a cofactor in T reg cell generation, providing a mechanism via which 
functionally specialized gut-associated lymphoid tissue DCs can extend the repertoire of 
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such antigen-loaded DCs may preferentially direct the induc-
tion or expansion of T cells with regulatory properties. In 
line with this, several previous studies have suggested that 
intestinal DCs may be tolerogenic (  11, 14  ). Moreover, a recent 
study has demonstrated a role for the migration of intestinal 
DCs through the lymph to the MLN in the induction of oral 
tolerance (  15  ). It therefore seemed likely that the induction 
of Foxp3 expression we observed upon the feeding of OVA 
could be mediated by DCs present in the MLNs. We there-
fore sought to investigate the role of MLN DCs in the induction 
of Foxp3      T reg cells. 
  CD103      DCs isolated from the MLNs promote 
the conversion of naive CD4      T cells into Foxp3      T cells 
  We have previously demonstrated that expression of CD103 
on DCs is required for the CD4     CD25      T reg cell  –  mediated 
control of experimental colitis (  16  ). This suggested that 
CD103      DCs may be functionally specialized to drive T reg cell 
responses. CD103 is expressed by a proportion of DCs isolated 
from the MLNs and colonic LP of normal mice and is also 
present on rat lymph DCs migrating from the intestine in the 
steady state (  Fig. 2 A  ) (  17  –  19  ).       Fittingly, in CCR7       /       mice, 
where the migration of DCs from tissue to the LN is impaired, 
the number of CD103      DCs in the MLNs is greatly reduced 
(  19  ). This suggests that a proportion of the CD103      DCs present 
  Here, we demonstrate that a population of CD103      DCs 
found in the mesenteric LNs (MLNs) of normal mice can 
promote the conversion of naive T cells into Foxp3      T reg cells. 
This occurred without any further manipulation of the DC 
population and was dependent on TGF-      and the vitamin A 
metabolite, retinoic acid (RA). These results highlight one path-
way by which T reg cells may be generated in the periphery 
under normal conditions. 
    RESULTS AND DISCUSSION   
  Oral administration of OVA induces Foxp3      T cells 
from naive precursors 
  Oral administration of antigen has been shown to increase 
T reg cell populations in a variety of experimental settings (  3, 
4, 13  ). However, whether this represents de novo induction 
or expansion of a preformed pool of Foxp3      T reg cells is not 
clear. Here, we have investigated the induction of Foxp3 ex-
pression in antigen-specifi  c T cells after oral administration of 
OVA to DO11.10 SCID mice. Placing a TCR transgene on 
the SCID background prevents endogenous rearrangement of 
TCR chains, resulting in all peripheral T cells having a single 
antigen specifi  city. As the antigen recognized by the DO11.10 
TCR is exogenous, T cells from unfed DO11.10 SCID mice 
are a uniformly naive population and do not express Foxp3. 
DO11.10 SCID mice are therefore a useful tool to investigate 
induction of Foxp3 expression rather than expansion of a pre-
existing population. When drinking water was supplemented 
with OVA, but not BSA, we observed a dramatic increase 
in MLN cellularity, including a proportionate increase in 
the number of CD4      T cells. This was accompanied by the 
formation of a small population of Foxp3      T cells in the MLN 
(  Fig. 1  ).       Populations of Foxp3      T cells were also detected in 
the spleen and colonic lamina propria (LP) of OVA-fed mice, 
although the increase in T cell numbers was moderate in com-
parison to the MLN (unpublished data). Foxp3      T cells were 
still detectable 5 d after the removal of antigen from the 
drinking water (Fig. S1, A and B, available at http://www.jem
.org/cgi/content/full/jem.20070590/DC1). 
  Expression of Foxp3 also occurred in naive peripheral 
DO11.10 SCID CD4      T cells adoptively transferred into 
congenic Ly9.2 BALB/c mice (Fig. S1, C  –  E). This supports 
the conclusion that Foxp3      T reg cells can arise from the pe-
ripheral T cell pool rather than from immature thymocytes, 
which may have occurred if antigen-loaded peripheral DCs 
migrated to the thymus of DO11.10 SCID mice. Further-
more, this fi  nding confi  rms that the presence of a normal 
T reg cell repertoire does not inhibit the peripheral generation 
of Foxp3      T reg cells. 
  Collectively, our results suggest that the GALT is one site 
at which the peripheral induction of Foxp3      T reg cells can 
occur. Although potential mediators for the peripheral in-
duction of Foxp3 expression have been studied, the factors 
governing their formation at this particular anatomical site 
remain unknown. Antigen administered by the oral route is 
likely to be picked up by DCs present in the Peyer  ’  s patches 
or LP. Upon encounter with T cells, most likely in the MLNs, 
  Figure 1.     Induction of Foxp3      T cells after oral administration 
of antigen. DO11.10 SCID mice were given OVA or BSA in drinking 
water for 5 d. (A) Single cell suspensions of MLNs stained for CD4 and 
Foxp3 and analyzed by FACS. Numbers represent the proportion of 
Foxp3      cells among the CD4      population. (B) Percentage of Foxp3     
cells among the CD4      population, and total number of Foxp3      cells  in 
OVA- and BSA-fed mice. Data are representative of two similar inde-
pendent experiments.     JEM VOL. 204, August 6, 2007  1759
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induce expression of Foxp3, which was detectable by FACS 
at days 3 and 7 of culture (  Fig. 2, B and C,   and not depicted). 
Induction of Foxp3 was dependent on the number of DCs 
present in culture, with a reduction in the number of CD103      
DCs leading to a decrease in the proportion of T cells ex-
pressing Foxp3 (  Fig. 2 B  ). CD103      MLN DCs isolated from 
OVA-fed mice also drove expression of Foxp3 when cultured 
with DO11.10 SCID CD4      T cells, indicating that CD103      
DCs are capable of taking up and presenting orally administered 
antigen (Fig. S3). However, very little CD4      T cell accumu-
lation was observed in the presence of CD103         DCs or when 
mice were fed an irrelevant antigen. 
  The ability of CD103      DCs to maintain a preexisting 
population of Foxp3     CD4     CD25      T cells in culture was 
also investigated. CD4     CD25      T cells were obtained from the 
spleens of DO11.10 BALB/c mice, and expression of Foxp3 
in the TCR transgenic (KJ-1.26     ) fraction was investigated. 
At the beginning of culture, 75% of KJ-1.26      T cells expressed 
Foxp3. Over the period of culture this proportion decreased, 
probably as a result of outgrowth of contaminating Foxp3         
T cells rather than a genuine down-regulation of Foxp3. 
However, the proportion of T cells expressing Foxp3 by day 
7 of culture was greater in the presence of CD103      DCs 
(  Fig. 2 D  ). This suggests that in addition to inducing Foxp3 
expression in naive T cells, CD103      DCs favor the maintenance 
of existing Foxp3      cells over expansion of any contaminating 
Foxp3         population. 
  We had previously observed that CD103      MLN DCs 
directed the migration of T cells to the intestine without 
inducing production of the proinfl  ammatory cytokine IFN-      
(  16  ). We now demonstrate that CD103      MLN DCs are 
capable both of converting naive T cells into Foxp3      T reg 
cells and of supporting conventional CD4     CD25     Foxp3      
T reg cells. Collectively, these data indicate that CD103      
MLN DCs are capable of driving T reg cell responses focused 
on the intestine. Because expression of CD103 on DCs was 
required for the CD4     CD25      T reg cell  –  mediated control of 
colitis, we speculate that both the transferred CD4     CD25      
T reg cells and the Foxp3      T reg cells generated peripherally 
from naive T cells may play an important role in the prevention 
of intestinal pathology. 
  TGF-      enhances the conversion of naive T cells into Foxp3      
cells in the presence of CD103      DCs 
  TGF-     1 is important in maintaining functional Foxp3    
CD4     CD25      T reg cells in the periphery and can also induce 
Foxp3 expression in naive T cells (  5  –  10, 20  ). Therefore, the role 
of TGF-      in the induction of Foxp3 by CD103      DCs was 
investigated. Naive T cells were again cultured with CD103      
or CD103         DCs. Inclusion of a blocking mAb against TGF-      
completely blocked the induction of Foxp3, indicating that 
the conversion of naive T cells into Foxp3      T reg cells by 
CD103      DCs is mediated by TGF-      (  Fig. 3 A  ). A possible 
explanation for the functional diff  erence between CD103      
and CD103         DC subsets is that CD103      DCs produce higher 
levels of active TGF-      than the CD103         population. Analysis 
in the MLNs migrate there constitutively from the intestine, 
making them likely candidates for the generation of T reg cell 
responses. We compared the ability of CD103      and CD103         
DCs isolated from the MLNs of normal BALB/c mice to 
induce expression of Foxp3 in splenic CD4      T cells isolated 
from DO11.10 SCID mice. Proliferation and accumulation 
of T cells was comparable in the presence of both CD103      
and CD103         DCs (Fig. S2, available at http://www.jem
.org/cgi/content/full/jem.20070590/DC1). However, it was 
striking that only the CD103      DC population was able to 
  Figure 2.     Induction of Foxp3      T cells in the presence of MLN 
CD103     DCs. (A) Single cell suspensions of spleen, MLNs, and colonic LP 
from BALB/c mice were prepared, and the proportion of CD103      cells 
among the CD11c  high   population was determined. (B) 0.25  –  1       10 5   CD103    
or CD103         MLN DCs were cultured with CFDA SE-labeled DO11.10 CD4     
T cells and 0.2      g/ml OVA peptide. At day 7 of culture, T cells were stained 
for Foxp3 and CD4 and analyzed by FACS. The graph shows the percent-
age of Foxp3      cells among CD4      T cells in the presence of varying num-
bers of either DC subset. Data is representative of three independent 
experiments. (C) FACS plots showing the percentage of T cells expressing 
Foxp3 at the start of culture and after 7 d of culture with 10  5   CD103 +   or 
CD103         MLN DCs. Plots are gated on CD4      cells, and numbers represent 
the proportion of CD4      cells in each quadrant. (D) CD4    CD25     T cells from 
DO11.10 mice were isolated and cultured with 10  5   CD103     or CD103         MLN 
DCs and 0.2      g/ml OVA peptide. Before culture, and at day 6 of culture, 
T cells were stained for CD4, Foxp3, and clonotypic TCR (KJ-1.26). Plots are 
gated on KJ-1.26    CD4     cells. Numbers represent the percentage of Foxp3     
cells among the KJ-1.26    CD4     population. Data are representative of two 
independent experiments.     1760 CD103      MLN DCS INDUCE FOXP3      T REG CELLS | Coombes et al.
of naive T cells into Foxp3      T cells, so that inclusion of 1 ng/ml 
TGF-      resulted in the expression of Foxp3 by     50% of  T cells. 
However, although inclusion of TGF-      in cultures containing 
CD103         DCs allowed for the generation of a minor Foxp3      
T cell population, the percentage of T cells expressing Foxp3 
was still considerably lower than in the presence of CD103      
DCs (  Fig. 3 C  ). 
  Although CD103      DCs express genes involved in the 
secretion and activation of latent TGF-     , this cannot account 
for their enhanced ability to induce Foxp3 in the presence of 
exogenous TGF-     . The exogenous TGF-      used in these ex-
periments was already in its active form, bypassing the need 
for the production of factors involved in the conversion of 
latent into active TGF-     . Even the provision of very high 
concentrations of active TGF-      did not enable CD103         DCs 
to induce similar levels of Foxp3 to CD103      DCs, suggesting 
either that CD103         DCs are producing an inhibitory factor 
or lack an important cofactor. 
  RA acts as a cofactor for Foxp3 induction 
  We and others have previously demonstrated that CD103      
DCs promote the expression of gut homing receptors on 
of gene expression by freshly isolated CD103      and CD103         
MLN DCs revealed several diff  erences in the expression of 
mRNA related to TGF-      and its secretion and activation 
(  Fig. 3 B  ). Specifi  cally, CD103      DCs expressed higher levels 
of   tgfb2  ,   plat   (tissue plasminogen activator), and latent TGF-      
binding protein 3 (  ltbp3  ). LTBP3 is important for the effi   cient 
secretion and appropriate localization of latent TGF-    , whereas 
tissue plasminogen activator plays a role in the activation of 
latent TGF-      (  21  ). 
  Although suffi   cient endogenous TGF-      was present in 
cultures containing CD103      DCs to mediate the conversion 
of     10% of naive T cells into Foxp3      T cells, we investigated 
the eff  ect of adding varying concentrations of exogenous 
TGF-      on the induction of Foxp3. The addition of TGF-      
to cultures containing CD103      DCs enhanced the conversion 
  Figure 3.     Induction of Foxp3 is dependent on TGF-     . (A) CD4     
T cells from DO11.10 SCID mice were cultured with 5       10 4   CD103     or 
CD103         MLN DCs, 0.2      g/ml OVA peptide, and 50      g/ml anti  –  TGF-      or 
isotype control. At day 6 of culture, T cells were stained for CD4 and 
Foxp3 and analyzed by FACS. Representative plots from two independent 
experiments are gated on CD4      cells, and numbers represent the percent-
age of CD4      cells in each quadrant. (B) CD103      and  CD103        DCs  were 
sorted from the MLNs of BALB/c mice.   Tgfb2 ,   ltbp3  , and   plat   gene  expres-
sion was assayed by quantitative PCR and normalized relative to expres-
sion of HPRT. Data shown are representative of two independent 
experiments. (C) CD4      T cells from DO11.10 SCID mice were cultured with 
10  5   CD103     or CD103         MLN DCs, 0.2 ug/ml OVA peptide, and the indicated 
concentrations of rhTGF-     . At day 6 of culture, T cells were stained for 
CD4 and Foxp3 and analyzed by FACS. Representative plots from three 
similar experiments are gated on CD4      cells, and numbers represent the 
percentage of Foxp3      cells among CD4      T  cells.   
  Figure 4.     RA acts as a cofactor for Foxp3 induction. (A) CD103     
and CD103         DCs were sorted from the MLNs of BALB/c mice.   Aldh1a2  
gene expression was assayed by quantitative PCR and normalized relative 
to expression of HPRT. Data shown are representative of two independent 
experiments. (B) CD4      T cells from DO11.10 SCID mice were cultured with 
5       10 4   CD103     or  CD103        MLN DCs, 0.2      g/ml OVA peptide, and 2 ng/ml 
rhTGF-     . Some wells were additionally supplemented with 100 nM RA. 
T cells were stained for      7 integrin, CD4, and Foxp3 and analyzed by FACS. 
Plots are gated on CD4      cells, and numbers represent the percentage of 
CD4      cells in each quadrant. Data are representative of two independent 
experiments. (C) Graph depicts pooled data from the experiments de-
scribed in B. Bars show the percentage of CD4      cells expressing Foxp3. 
(D) Graph depicts absolute numbers of Foxp3      T cells in culture under the 
indicated  conditions.   JEM VOL. 204, August 6, 2007  1761
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However, it is crucial that protective immunity to intestinal 
pathogens can also be mounted. To this end, we investigated the 
functional properties of the reciprocal CD103         DC population. 
Purifi  ed CD103      and CD103         MLN DCs were cultured 
overnight either alone or in the presence of LPS or an agonist 
anti-CD40 mAb. Cytokines in the supernatants were quanti-
tated by cytometric bead array, whereas levels of cytokine 
mRNA in the DCs were determined by quantitative PCR. 
CD103         DCs produced higher levels of TNF-      regardless of 
whether DCs were left unstimulated or activated with LPS or 
anti-CD40. However, treatment with LPS did increase the 
levels of TNF-      present in the supernatants of CD103         DC     
(Fig. 5 A).       LPS treatment also led to the enhanced production 
of IL-6 by CD103         DCs (Fig. 5 A). Furthermore, CD103         
DCs produce substantially higher levels of IL-23p19 mRNA 
than CD103      DCs after stimulation through CD40. Only a 
comparatively moderate increase in the expression of IL-12p40 
was observed (Fig. 5 B). Consistent with their increased pro-
duction of TNF-      and IL-6 in response to LPS stimulation, 
CD103         DCs also expressed slightly higher levels of Toll-like 
receptor (TLR)4 mRNA than CD103      DCs. Further evidence 
T cells (  16, 19  ). Expression of gut homing receptors on T cells 
is enhanced by the vitamin A metabolite RA (  22  ). Accord-
ingly, we now show that CD103      DCs express   aldh1a2  , a 
retinal dehydrogenase involved in the conversion of retinal 
into RA (  Fig. 4 A  ).       As a result, we investigated whether the 
provision of vitamin A was an important factor in the con-
version of naive T cells into Foxp3      T cells. As expected, the 
culture of T cells with exogenous TGF-      and CD103      DCs 
led to the generation of a greater proportion of Foxp3      T 
cells than did culture with TGF-      and CD103         DCs (  Fig. 4, 
B  –  D  ). However, the addition of both TGF-      and RA to 
cultures led to the generation of a similar proportion and 
number of Foxp3      T cells in the presence of both CD103         
and CD103      DCs (  Fig. 4, B-D  ). Foxp3      T cells generated in 
this way were still detectable after 17 d in culture, regardless 
of whether or not exogenous TGF-      and RA continued to 
be provided (Fig. S4, available at http://www.jem.org/cgi/
content/full/jem.20070590/DC1). It would therefore appear 
that RA is a necessary cofactor for the effi   cient TGF-       – 
mediated conversion of naive T cells into Foxp3      T reg cells. 
In addition, inclusion of synthetic RA receptor inhibitors 
(LE540 and LE135) blocked the spontaneous induction of 
Foxp3 seen in the presence of CD103      MLN DCs (Fig. S5). 
The ability of CD103      DCs to metabolize vitamin A is there-
fore likely to account for their ability to drive the spontane-
ous conversion of naive T cells into Foxp3      T cells in the 
absence of any exogenous factors. 
  Converted Foxp3      T cells suppress naive T cell proliferation 
in vitro 
  Expression of Foxp3 can be transiently up-regulated upon T cell 
activation in the absence of an accompanying acquisition of 
regulatory properties (  23  ). It was therefore important to test the 
ability of Foxp3      T cells generated in the presence of CD103      
MLN DCs to suppress the proliferation of naive T cells. Be-
cause live cells cannot be sorted on the basis of Foxp3 expres-
sion in the absence of a reporter gene, we could not test the 
suppressive function of the Foxp3      T cells generated using the 
experimental setup described above. Instead, GFP        CD4      T cells 
were isolated from Foxp3-GFP mice and activated in the pres-
ence of CD103      DCs and anti-CD3    . This led to the generation 
of a similar proportion of Foxp3      T cells as in the antigen-
  specifi  c system. Again, this induction of Foxp3 could be inhib-
ited by the inclusion of anti  –  TGF-      or RA receptor inhibitors 
and could be enhanced by the inclusion of rhTGF-      and RA 
(Fig. S5). Foxp3      T cells generated in the presence of CD103      
DCs and rhTGF-      were then sorted on the basis of GFP ex-
pression and their ability to suppress the proliferation of naive 
T cells compared with that of freshly isolated Foxp3      T reg cells. 
Foxp3      T cells generated in this way were able to suppress the 
proliferation of naive T cells, indicating that they represent a true 
regulatory population (Fig. S5). 
  CD103         DCs produce proinfl  ammatory cytokines 
  We have demonstrated a clear role for MLN CD103      DCs in 
the induction of Foxp3 and regulatory function in naive T cells. 
  Figure 5.     CD103         DCs produce proinfl  ammatory cytokines. CD103     
and CD103         DCs were sorted from the MLN of BALB/c mice and cultured 
overnight in the presence of anti-CD40, an isotype control, or LPS. 
(A) Supernatants were harvested, and cytokine concentrations were analyzed 
by cytometric bead array. Graphs are representative of two independent 
experiments and depict cytokine concentrations in pg/ml. (B) IL-12p40 
and IL-23p19 gene expression was assayed by quantitative PCR and 
  normalized relative to expression of HPRT. Data are representative of two 
independent experiments. (C) CD103      and  CD103        DCs were sorted from 
the MLN of BALB/c mice.   Tlr2 ,   tlr4 ,  and   tbx21   gene expression was assayed 
by quantitative PCR and normalized relative to expression of HPRT. Data 
are representative of two independent experiments.     1762 CD103      MLN DCS INDUCE FOXP3      T REG CELLS | Coombes et al.
for in vitro stimulation of T cells was clone 145-2C11 (BD Biosciences). 
Anti  –  mouse CD4 (L3T4), anti  –  mouse      7 integrin (M293), and anti  –  mouse 
     4     7 (DATK32; all from BD Biosciences); anti  –  mouse Foxp3 (FJK-16S; 
eBioscience); and biotinylated or FITC-labeled anti-clonotypic TCR (KJ-1.26) 
were used for analysis of T cell populations. 
  Adoptive transfer and oral feeding of antigen.     CD4      T cells were 
isolated from splenic single cell suspensions from DO11.10-SCID mice by 
labeling with magnetic anti-CD4 beads (Miltenyi Biotec) and separating the 
cell populations using LS MACS columns according to the manufacturer  ’  s 
instructions. 2.5       10  6   cells were injected i.v. into Ly9.2 BALB/c recipients. 
After 24 h, drinking water was supplemented with 20 mg/ml Grade VI OVA 
(Sigma-Aldrich) as described previously (  13  ). Antigen was administered to 
intact DO11.10 SCID mice in the same way. At the time points indicated 
in the relevant fi  gure legends, organs were harvested and the presence of 
Foxp3      T cells was determined by FACS. 
  Preparation and culture of CD11c  high   subsets.     MLNs from BALB/c 
mice were cut into small fragments and incubated in RPMI with 10% FCS, 
15 mM Hepes, and 1 mg/ml collagenase type VIII (Sigma-Aldrich) for 
40 min at 37  °  C in a shaking incubator. After adding EDTA for an addi-
tional 5 min, the solution was fi  ltered through a nylon mesh and washed in 
HBSS with 0.1% BSA. Cell suspensions were incubated with an anti-FcR 
antibody (clone 24G2; eBioscience), followed by anti-CD11c MACS beads 
(Miltenyi Biotec). CD11c      cells were positively selected on an LS MACS 
column according to the manufacturer  ’  s instructions (Miltenyi Biotec). 
Cells were labeled with anti-CD3e, anti-CD103, anti-CD11c, and 7-AAD 
and sorted on a MoFlo sorter (DakoCytomation) to      98% purity. For anal-
ysis of cytokine production, DC subsets were cultured overnight in DMEM 
supplemented with 10% FCS, 2 mM L-glutamine, and 100 U of penicillin 
and streptomycin. 1 ug/ml LPS (Sigma-Aldrich) or 10 ug/ml anti  –  mouse 
CD40 was added to some wells. Supernatants were analyzed for cytokines using 
a Cytometric Bead Array mouse infl  ammation kit according to the manu-
facturer  ’  s instructions (BD Biosciences). Cells were prepared for quantitative 
PCR analysis as described below. 
  Preparation of T cell populations.     CD4      T cells were isolated from 
splenic single cell suspensions from DO11.10 SCID mice by labeling with 
magnetic anti-CD4 beads (Miltenyi Biotec) and separating the cell popula-
tions using LS MACS columns according to the manufacturer  ’  s instructions. 
The positively selected CD4      T cells were labeled with 10      M CFDA SE 
using a Vybrant CFDA SE Cell Tracer kit (Invitrogen). CD4     CD25      T cells 
were isolated from the spleens of DO11.10 BALB/c mice. Single cell sus-
pensions were depleted of CD8     , MHC class II     , Mac-1     , and B220      cells 
by negative selection using sheep anti  –  rat-coated Dynabeads (Dynal) as de-
scribed previously (  26  ). The resulting CD4-enriched cells were stained with 
biotinylated anti  –  mouse CD25, followed by Straptavidin-coated MACS beads 
and sorted by AutoMACS (Miltenyi Biotec). 
  T cell diff  erentiation assay.     2       10  5   T cells were cultured together with 
2.5       10  4    –  10  5   of the sorted CD11c  high   subsets and 0.2      g/ml OVA peptide 
in complete RPMI (10% FCS, 2 mM L-glutamine, 0.05 mM 2-mercapto-
ethanol, and 100 U of penicillin and streptomycin) for 4 d. Cultures were 
supplemented with fresh medium containing 100 U/ml recombinant human 
IL-2 (PeproTech) and incubated for an additional 2  –  3 d. Alternatively, 10  5   
CD4     eGFP         T cells were cultured with 10  4   purifi  ed CD103      or CD103         
MLN DCs and 1      g/ml of soluble anti-CD3 for 5 d. 5 ng/ml of recombi-
nant human IL-2 was added to cultures every other day beginning on day 2 
as described previously (  25  ). On day 5, cells were stained with PE-Cy7  – 
conjugated anti-CD4 (RM4-5), and Foxp3      cells were detected by eGFP 
expression. Recombinant human TGF-     1 (R  &  D Systems), anti  –  mouse 
TGF-     1/2, all-trans RA (Sigma-Aldrich), or the RA receptor inhibitors, 
LE540 (Wako Chemicals USA) and LE135 (Tocris Bioscience), were added 
to culture wells in some cases. Concentrations are indicated in the relevant 
fi  gure legends. 
for the more proinfl  ammatory phenotype of CD103         DCs 
included the enhanced expression of   tlr2   and   tbx21  , which 
encodes Tbet (Fig. 5 C). 
  The data presented here raise the question of why the 
functional properties of CD103      and CD103         DCs diff  er so 
dramatically. It is likely that the CD103      DC subset has arrived 
in the MLNs from the intestine and, consequently, its journey 
through the immunosuppressive intestinal environment may 
have left an impact on its function. We hypothesize that the 
interaction between CD103 on DCs and E-cadherin on 
epithelial cells may tether the DCs close to the intestinal epi-
thelium. This would allow them to be conditioned, perhaps by 
epithelial cell  –  derived factors, to go on to drive regulatory-
type responses in the draining LNs. An example of this is 
the conditioning of DCs by thymic stromal lymphopoietin     
produced by intestinal epithelial cells (  24  ). A key feature of gut 
conditioning in our studies is the capacity of CD103      DCs to 
produce or activate TGF-      and to provide RA, both essential 
cofactors for the emergence of Foxp3      T cells. In this way, 
gut-derived DCs respond to environmental cues to promote 
noninfl  ammatory immune-suppressive responses that may con-
tribute to intestinal homeostasis. On the other hand, CD103         
DCs may have arrived in the LNs through the blood and 
therefore escaped gut conditioning. This would leave them 
poised to respond to infl  ammatory stimuli through the pro-
duction of proinfl  ammatory cytokines. 
  Our results demonstrate the presence of two functionally 
distinct DC subsets present in the MLNs of normal mice. 
CD103         DCs are poised to deal with pathogens through the 
production of proinfl  ammatory cytokines, whereas CD103      
DCs induce Foxp3      T reg cells, suggesting a mechanism by 
which tolerance to harmless non  –  self-antigen may be main-
tained. The ability to induce or expand populations of T reg 
cells in culture increases the likelihood that they could be used 
therapeutically, for example, in the treatment of infl  ammatory 
bowel disease. Identifi  cation of the key factors involved in the 
induction of T reg cells by CD103      DCs suggests ways in which 
this process can be made more effi   cient. In this regard, the 
fi  nding that RA enhances the TGF-       –  mediated induction of 
Foxp3 may have important therapeutic implications. 
  MATERIALS AND METHODS 
  Mice.     BALB/c, DO11.10 BALB/c, and DO11.10 SCID TCR transgenic 
mice were maintained in microisolator cages in a specifi  c pathogen-free animal 
facility at the University of Oxford. Experiments were performed according 
to the UK Animals (Scientifi  c Procedures) Act of 1986. Foxp3 eGFP re-
porter mice (Foxp3  GFP  ) were originally obtained from M. Oukka     (Harvard 
Medical School, Boston, MA) (  25  ) and were maintained in the NIH  ’  s animal 
facilities under specifi  c pathogen-free conditions. 
  Antibodies.     The following antibodies were used for cell purifi  cation: anti  –
  mouse CD8 (clone YTS169), MHC class II (TIB120), Mac-1 (M1/70), 
and B220 (RA3-6B2; all purifi  ed from hybridoma supernatant by affi   nity 
chromatography); and biotinylated anti  –  mouse CD25 (7D4), anti  –  mouse 
CD11c (clone HL3), anti  –  mouse CD103 (M290), and anti  –  mouse CD3e 
(145-2C11; all from BD Biosciences). For use in in vitro cultures, anti  –  mouse 
TGF-     1/2 (1D11.16.8) and anti  –  mouse CD40 (FGK45) were purifi  ed from 
hybridoma supernatant by affi   nity chromatography. Anti  –  mouse CD3 used JEM VOL. 204, August 6, 2007  1763
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  Suppression assay.     The ability of Foxp3      T cells generated in the presence 
of CD103      DCs to suppress T cell proliferation was determined as described 
previously (  27  ). In brief, sorted CD4     GFP      T reg cells were cultured with 5       
10  4   freshly isolated CD4     GFP         T cells, 10  5   antigen-presenting cells, and 
0.5      g/ml anti-CD3 (145-2C11; BD Biosciences). Antigen-presenting cells 
were prepared by depleting splenocytes of CD90      cells by isolation kit and 
autoMACs (Miltenyi Biotec), followed by irradiation. Cultures were incu-
bated for 72 h, with the inclusion of 1      Ci/well [  3  H]TdR (MP Biomedicals) 
for the fi  nal 8 h. 
  Quantitation of gene expression using real-time PCR.     Total RNA was 
purifi  ed from sorted cells using RNAeasy kits (QIAGEN). cDNA synthesis 
was performed using Superscript III reverse transcriptase and Oligo dT primers 
(both from Invitrogen). Quantitative PCR reactions were performed either 
using quantitect Primer Assays with SYBR green PCR mastermix (QIAGEN) 
or the following reagents: IL-23 p19 primer AGCGGGACATATGAATC-
TACTAAGAGA, GTCCTAGTAGGGAGGTGTGAAGTTG, and FAM/
TAMRA-labeled probe CCAGTTCTGCTTGCAAAGGATCCGC; IL-12 
p40 primers GACCATCACTGTCAAAGAGTTTCTAGAT, AGGAAA-
GTCTTGTTTTTGAAATTTTTTAA, and FAM/TAMRA-labeled probe 
CCACTCACATCTGCTGCTCCACAAGAAG; HPRT primers GACCG-
GTCCCGTCATGC and TCATAACCTGGTTCATCATCGC; and VIC/
TAMRA-labeled probe ACCCGCAGTCCCAGCGTCGTC. 
  cDNA samples were assayed in triplicate using a Chromo4 detection 
system (MJ Research), and gene expression levels for each individual sample 
were normalized to HPRT. Mean relative gene expression was determined 
and the diff  erences were calculated using the 2            C(t)   method (  28  ). 
  Statistics.     An unpaired student  ’  s   t   test was performed in Prism (Graphpad) 
in all cases. Where appropriate, mean       SD is represented on graphs. 
  Online supplemental material.     Fig. S1 shows the generation of Foxp3      
T cells in the GALT. Foxp3      T cells are maintained in the MLN of DO11.10 
SCID mice after the removal of antigen and can be generated after the transfer 
of DO11.10 SCID T cells to normal mice. Fig. S2 shows the accumulation 
and proliferation of CD4      T cells in the presence of CD103      and CD103         
DCs. Fig. S3 shows that CD103      DCs can acquire and present orally admin-
istered antigen. Fig. S4 shows that Foxp3      T cells continue to accumulate in 
culture without the continued provision of TGF-      and RA. Fig. S5 shows that 
induction of Foxp3 by CD103      DCs is inhibited by RA receptor inhibitors, 
and that Foxp3      T cells generated in vitro can suppress T cell proliferation. 
The online supplemental material can be found at http://www.jem.org/cgi/
content/full/jem.20070590/DC1. 
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